SMTL ID : 5th2.1 (1 other biounit)

Cetuximab Fab in complex with L5Q meditope variant

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.84 Å

Oligo State

hetero-1-1-1-mer

Ligands

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.1: 4 residues within 4Å: Chain A: E.165, D.167 Chain B: V.169, H.170 6 PLIP interactions: 4 interactions with chain A, 2 interactions with chain B Water bridges: A:T.164, A:S.168, A:S.168, A:K.169, B:T.171 Salt bridges: B:H.170 PO4.2: 5 residues within 4Å: Chain B: N.205, K.207, N.210, T.211, K.212 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:N.205, B:N.205, B:N.210 Salt bridges: B:K.212

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bzymek, K.P. et al., Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun (2016)

Release Date

2016-10-26

Peptides

cetuximab Fab, light chain: A
cetuximab Fab, heavy chain: B
L5Q meditope: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
E

cetuximab Fab, light chain

cetuximab Fab, heavy chain

L5Q meditope

Related Entries With Identical Sequence